Dr G Peat, Primary Care Sciences Research Centre, School of Postgraduate Medicine, Keele University, The Medical Institute, Hartshill Road, Stoke-on-Trent ST7 4NY, UKg.m.peat{at}hfac.keele.ac.uk ...

1 Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands 2 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 3 Department of ...

Background: Heterogeneous data have been reported regarding the detection and number of circulating endothelial progenitor cells (EPCs) in systemic sclerosis (SSc). Objective: We investigated the ...

1 Department of Rheumatology, University Medical Centre, Nijmegen, The Netherlands 2 Tumour Immunology, University Medical Centre, Nijmegen, The Netherlands 3 ...

1 Department of Orthopaedic and Trauma Surgery, Tampere University Hospital, Tampere, Finland 2 Department of Physical Medicine and Rehabilitation, Jyväskylä Central Hospital, Jyväskylä, Finland 3 ...

Department of Internal Medicine, Division of Rheumatology, University of Maastricht, Maastricht, The Netherlands Correspondence to: Professor D van der Heijde Department of Internal Medicine, Division ...

Objective: To evaluate the efficacy and safety of adding sulfasalazine to leflunomide treatment compared with switching to sulfasalazine alone in patients with RA with an inadequate response to ...

Objective To determine a concentration–effect curve of adalimumab in rheumatoid arthritis (RA) patients taking into account the effect of methotrexate (MTX) on concentration and effect and to identify ...

Bone Research Group and Auckland Rheumatology Imaging Group, University of Auckland, Auckland, New Zealand Dr N Dalbeth, Bone Research Group, Department of Medicine, Faculty of Medical and Health ...

Objective This observational cohort study investigated the impact of biological (b) disease-modifying antirheumatic drugs (DMARDs) on the outcomes of serious infections (SIs) in patients with ...

Correspondence to Professor Johan Askling, Clinical Epidemiology Unit (T2), Department of Medicine (Solna), Karolinska Institutet, Stockholm SE-17176, Sweden; johan.askling{at}ki.se Aims To assess and ...

Objectives To compare the effect of a single infusion of zoledronic acid (ZA) with placebo on knee pain and bone marrow lesions (BMLs). Methods Adults aged 50–80 years (n=59) with clinical knee ...